BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

LIBRAINFU

All Eps Dividend Board Agm Q1 Q2 Q3

LIBRAINFU 16-May-2021

The auditor of the Libra Infusions Limited has given the "Qualified Opinion" paragraphs in the Auditor's Report for the year ended on June 30, 2019. Basis for Qualified Opinion: 1. No Depreciation has been charged for the fixed assets in Unit-2 during the year which would be Tk. 37,345,698 approximately. Further, deferred tax for revaluation of building and construction of the unit has also not been recognized. (cont.1)

LIBRAINFU 03-May-2021

Trading of the shares of the company will resume on 04.05.2021 after record date.

LIBRAINFU 02-May-2021

Trading of the shares of the Company will remain suspended on record date i.e., 03.05.2021.

LIBRAINFU 28-Apr-2021

Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 29.04.2021 to 02.05.2021. Trading of the shares of the Company will remain suspended on record date i.e., 03.05.2021.

LIBRAINFU 13-Apr-2021

There will be no price limit on the trading of the shares of the Company today (13.04.2021) following its corporate declaration, however, as per the BSEC Order No. BSEC/CMRRCD/2001-07/04 dated March 19, 2020, the floor price shall be applicable accordingly.

LIBRAINFU 13-Apr-2021

The Board of Directors has recommended 5% cash dividend for the year ended on June 30, 2019. Date of AGM: 24.05.2021, Time: 11:00 AM, Venue: Digital Platform. Record Date: 03.05.2021. The Company has also reported EPS of Tk. 1.05, NAV per share of Tk. 1,269.00 and NOCFPS of Tk. 9.77 for the year ended on June 30, 2019 as against Tk. 4.60, Tk. 1,521.00 and Tk. 3.39 respectively for the same period of the previous year.

LIBRAINFU 06-Apr-2021

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has further informed that the meeting of the Board of Directors of the Company will now be held on April 12, 2021 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2019.

LIBRAINFU 08-Mar-2021

The Company has further informed that, due to unavoidable circumstances, the Board meeting as per LR 19(1), scheduled to be held on March 07, 2021 at 4:00 PM, to consider, among others, audited financial statements of the Company for the year ended on June 30, 2019, has been postponed. New date and time of the meeting will be notified later on.

LIBRAINFU 24-Feb-2021

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on March 07, 2021 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2019.

LIBRAINFU 02-Sep-2020

DSE NEWS: The Stock Brokers and Merchant Bankers are requested to abstain from providing loan facilities to purchase security of Libra Infusions Limited in between 1st to 30th trading day after change of categorization, with effect from Today, September 02, 2020 as per BSEC Directive No. SEC/CMRRCD/2009-193/177 and BSEC Order No. SEC/CMRRCD/2009-193/178 dated October 27, 2015.

Previous Next page